According to Coherent Market Insights (CMI), the global sickle cell disease treatment market size is expected to expand from USD 3.20 Bn in 2025 to USD 8.81 Bn by 2032, recording a CAGR of 15.6% ...

The Centers for Medicare and Medicaid Services has named 33 states, as well as Washington, D.C., and Puerto Rico, as participants in its Cell and Gene Therapy Access Model, which is designed to treat ...

Gujarat has launched a groundbreaking Tribal Genome Sequencing Project, aiming to improve healthcare in tribal communities by understanding genetic health risks. Spearheaded by Tribal Development ...

Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the best oversold NASDAQ stocks to buy now. On July 1, Beam Therapeutics Inc.

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

CMS is brokering outcomes-based agreements on behalf of Medicaid programs. Thirty-three states, along with Washington, D.C., ...

States representing about 84% of Medicaid beneficiaries are participating in an initiative that enables the U.S. government ...

CMS has reached agreements with drug manufacturers to provide gene therapies to treat sickle cell disease to Medicaid recipients under a new outcomes-based model. A total of 33 states, including the ...

Researchers report that eight healthy babies were born with the help of an experimental technique that uses DNA from three ...

Gujarat has become the first Indian state to launch a Tribal Genome Sequencing Project, aiming to enhance healthcare for ...

Columnist Oluwatosin Adesoye, a doctor, sorts through the difference between sickle cell anemia and sickle cell disease — and more.